Market Closed -
Nyse
21:00:02 17/05/2024 BST
|
5-day change
|
1st Jan Change
|
26.09
USD
|
+0.93%
|
|
+4.11%
|
-4.36%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
21,221
|
18,071
|
15,374
|
11,668
|
11,946
|
11,339
|
-
|
-
|
Enterprise Value (EV)
1 |
22,991
|
19,999
|
17,423
|
14,190
|
11,946
|
13,895
|
13,569
|
13,243
|
P/E ratio
|
35.5
x
|
40.3
x
|
29.3
x
|
52.6
x
|
45.6
x
|
22.1
x
|
16.9
x
|
14.3
x
|
Yield
|
1.54%
|
1.82%
|
2.14%
|
2.79%
|
-
|
2.94%
|
3.3%
|
3.7%
|
Capitalization / Revenue
|
4.13
x
|
3.96
x
|
2.95
x
|
2.24
x
|
2.15
x
|
1.95
x
|
1.85
x
|
1.76
x
|
EV / Revenue
|
4.47
x
|
4.39
x
|
3.34
x
|
2.72
x
|
2.15
x
|
2.39
x
|
2.22
x
|
2.05
x
|
EV / EBITDA
|
14.9
x
|
18
x
|
13
x
|
10.7
x
|
8.16
x
|
9.36
x
|
8.3
x
|
7.7
x
|
EV / FCF
|
30.3
x
|
40.6
x
|
37.1
x
|
129
x
|
-
|
24.6
x
|
19.5
x
|
17.5
x
|
FCF Yield
|
3.31%
|
2.46%
|
2.69%
|
0.78%
|
-
|
4.06%
|
5.14%
|
5.71%
|
Price to Book
|
4.15
x
|
3.43
x
|
2.76
x
|
2.23
x
|
-
|
2.1
x
|
2
x
|
1.91
x
|
Nbr of stocks (in thousands)
|
873,334
|
875,215
|
878,536
|
869,496
|
870,199
|
871,947
|
-
|
-
|
Reference price
2 |
24.30
|
20.65
|
17.50
|
13.42
|
13.73
|
13.00
|
13.00
|
13.00
|
Announcement Date
|
20/02/20
|
18/02/21
|
22/02/22
|
21/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,138
|
4,560
|
5,212
|
5,215
|
5,549
|
5,817
|
6,121
|
6,454
|
EBITDA
1 |
1,544
|
1,108
|
1,345
|
1,324
|
1,464
|
1,484
|
1,634
|
1,719
|
EBIT
1 |
1,169
|
683
|
936
|
901
|
970
|
1,059
|
1,219
|
1,333
|
Operating Margin
|
22.75%
|
14.98%
|
17.96%
|
17.28%
|
17.48%
|
18.21%
|
19.92%
|
20.65%
|
Earnings before Tax (EBT)
1 |
743
|
246
|
586
|
235
|
290
|
636.8
|
818.4
|
957.2
|
Net income
1 |
600
|
448
|
524
|
223
|
263
|
540.9
|
693.7
|
784.8
|
Net margin
|
11.68%
|
9.82%
|
10.05%
|
4.28%
|
4.74%
|
9.3%
|
11.33%
|
12.16%
|
EPS
2 |
0.6840
|
0.5120
|
0.5970
|
0.2550
|
0.3010
|
0.5890
|
0.7705
|
0.9091
|
Free Cash Flow
1 |
760
|
492
|
469
|
110
|
-
|
563.9
|
697.4
|
756.8
|
FCF margin
|
14.79%
|
10.79%
|
9%
|
2.11%
|
-
|
9.69%
|
11.39%
|
11.73%
|
FCF Conversion (EBITDA)
|
49.22%
|
44.4%
|
34.87%
|
8.31%
|
-
|
38.01%
|
42.68%
|
44.02%
|
FCF Conversion (Net income)
|
126.67%
|
109.82%
|
89.5%
|
49.33%
|
-
|
104.25%
|
100.54%
|
96.44%
|
Dividend per Share
2 |
0.3750
|
0.3750
|
0.3750
|
0.3750
|
-
|
0.3822
|
0.4286
|
0.4817
|
Announcement Date
|
20/02/20
|
18/02/21
|
22/02/22
|
21/02/23
|
27/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
2,653
|
2,035
|
2,525
|
2,599
|
1,266
|
1,346
|
2,613
|
1,306
|
1,293
|
2,600
|
1,250
|
1,365
|
2,615
|
1,356
|
1,379
|
2,734
|
1,357
|
1,458
|
2,815
|
1,398
|
1,450
|
2,830
|
1,429
|
1,548
|
2,988
|
1,464
|
2,994
|
3,142
|
EBITDA
|
825
|
360
|
748
|
666
|
-
|
-
|
679
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
637
|
172
|
511
|
459
|
-
|
-
|
477
|
-
|
-
|
440
|
-
|
-
|
461
|
-
|
-
|
417
|
-
|
-
|
553
|
-
|
-
|
466.5
|
-
|
-
|
551.6
|
-
|
596
|
644
|
Operating Margin
|
24.01%
|
8.45%
|
20.24%
|
17.66%
|
-
|
-
|
18.25%
|
-
|
-
|
16.92%
|
-
|
-
|
17.63%
|
-
|
-
|
15.25%
|
-
|
-
|
19.64%
|
-
|
-
|
16.49%
|
-
|
-
|
18.46%
|
-
|
19.91%
|
20.5%
|
Earnings before Tax (EBT)
|
360
|
-34
|
280
|
223
|
-
|
-
|
-
|
-
|
-
|
204
|
-
|
-
|
31
|
-
|
-
|
211
|
-
|
-
|
79
|
-
|
-
|
256
|
-
|
-
|
392.5
|
-
|
399
|
446
|
Net income
|
291
|
100
|
348
|
205
|
-
|
-
|
319
|
-
|
-
|
177
|
-
|
-
|
46
|
-
|
-
|
171.6
|
-
|
-
|
91
|
-
|
-
|
206
|
-
|
-
|
316
|
-
|
321
|
359
|
Net margin
|
10.97%
|
4.91%
|
13.78%
|
7.89%
|
-
|
-
|
12.21%
|
-
|
-
|
6.81%
|
-
|
-
|
1.76%
|
-
|
-
|
6.28%
|
-
|
-
|
3.23%
|
-
|
-
|
7.28%
|
-
|
-
|
10.57%
|
-
|
10.72%
|
11.43%
|
EPS
|
0.3320
|
0.1140
|
0.3980
|
0.2330
|
-
|
-
|
0.3640
|
-
|
-
|
0.2020
|
-
|
-
|
0.0530
|
-
|
-
|
0.1970
|
-
|
-
|
0.1040
|
-
|
-
|
0.2200
|
-
|
-
|
0.3700
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1440
|
-
|
-
|
0.2310
|
-
|
-
|
0.1440
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/02/20
|
29/07/20
|
18/02/21
|
29/07/21
|
04/11/21
|
22/02/22
|
22/02/22
|
28/04/22
|
28/07/22
|
28/07/22
|
03/11/22
|
21/02/23
|
21/02/23
|
03/05/23
|
03/08/23
|
03/08/23
|
02/11/23
|
27/02/24
|
27/02/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,770
|
1,928
|
2,049
|
2,522
|
-
|
2,555
|
2,229
|
1,904
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.146
x
|
1.74
x
|
1.523
x
|
1.905
x
|
-
|
1.722
x
|
1.364
x
|
1.107
x
|
Free Cash Flow
1 |
760
|
492
|
469
|
110
|
-
|
564
|
697
|
757
|
ROE (net income / shareholders' equity)
|
17.8%
|
10.8%
|
13.1%
|
13.2%
|
-
|
14.1%
|
15.9%
|
16.6%
|
ROA (Net income/ Total Assets)
|
10.3%
|
5.55%
|
6.47%
|
6.83%
|
-
|
6.2%
|
7.85%
|
8.5%
|
Assets
1 |
5,831
|
8,072
|
8,093
|
3,266
|
-
|
8,725
|
8,836
|
9,232
|
Book Value Per Share
2 |
5.860
|
6.020
|
6.350
|
6.030
|
-
|
6.180
|
6.500
|
6.810
|
Cash Flow per Share
2 |
1.330
|
1.070
|
1.000
|
0.5400
|
-
|
1.270
|
1.440
|
1.180
|
Capex
1 |
408
|
443
|
408
|
358
|
-
|
449
|
464
|
483
|
Capex / Sales
|
7.94%
|
9.71%
|
7.83%
|
6.86%
|
-
|
7.72%
|
7.59%
|
7.48%
|
Announcement Date
|
20/02/20
|
18/02/21
|
22/02/22
|
21/02/23
|
27/02/24
|
-
|
-
|
-
|
Average target price
16.35
USD Spread / Average Target +25.69% Consensus |
1st Jan change
|
Capi.
|
---|
| +11.76% | 127B | | +4.02% | 9.04B | | +38.12% | 5.56B | | -23.70% | 4.72B | | +8.55% | 3.45B | | -6.44% | 2.86B | | -5.85% | 2.07B | | -11.84% | 2.04B | | -23.36% | 1.77B |
Medical Devices & Implants
|